Ben Synth examines how Ozempic became America's most sought-after prescription, overwhelming supply chains with a 442% demand surge in three years. The episode covers viral cultural adoption, manufacturing constraints, the diabetes patient crisis, telehealth's role, and Novo Nordisk's multibillion-dollar expansion as the system struggles to catch up with explosive, ongoing demand.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
続きを読む
一部表示